Orris

Role of coenzyme Q10 in heart health

Reading File
Searching the Web

Coenzyme Q10 heart health heart failure evidence guideline 2025

Reading File
Finding Sources
Searching PubMed

"coenzyme Q10" AND "heart failure"

Reading File
Reading Article

PMID: 39462324

Reading Article

PMID: 39049769

Coenzyme Q10 (CoQ10, or ubiquinone) is a naturally occurring compound involved in mitochondrial energy production and antioxidant defense. The heart has a high energy demand, so this is the biological rationale for studying CoQ10 in cardiovascular disease. Katzung's Basic and Clinical Pharmacology, 16th ed., p. 1780.

What evidence suggests

  • Heart failure: CoQ10 has the most supportive evidence as an add-on treatment in chronic heart failure, not as a replacement for prescribed therapy. A 2024 meta-analysis of 33 randomized trials reported lower all-cause mortality (RR 0.64) and heart-failure hospitalizations (RR 0.50), with modest improvement in exercise capacity and ejection fraction. Evidence quality varied by outcome. 2024 meta-analysis
  • Cardiac pumping function: Improvements in left-ventricular ejection fraction appear small on average. Textbook evidence cites about a 3.7% short-term increase, and whether this applies to people receiving modern, guideline-directed heart-failure treatment is uncertain. Katzung's Basic and Clinical Pharmacology, 16th ed., p. 1780.
  • Blood pressure: It may produce a small reduction in blood pressure in some people, but data are not strong enough to use it instead of standard antihypertensive medication. Katzung's Basic and Clinical Pharmacology, 16th ed., p. 1780.
  • Coronary artery disease and angina: Evidence is limited and effects, if present, are modest. It has not been shown to prevent heart attacks or replace cholesterol-lowering, antiplatelet, or anti-anginal treatment.

Practical interpretation

CoQ10 can be discussed with a cardiologist for someone with symptomatic chronic heart failure, particularly if they are already on recommended heart-failure medicines. It should not delay or replace treatments with established benefit, such as ACE inhibitor/ARB/ARNI therapy, evidence-based beta-blockers, mineralocorticoid receptor antagonists, SGLT2 inhibitors, diuretics when needed, and appropriate device therapy.

Safety and interactions

CoQ10 is usually well tolerated. Possible adverse effects include stomach upset, nausea, diarrhea, and insomnia. The main interaction is important: because of structural similarity to vitamin K, it can reduce the anticoagulant effect of warfarin, so INR monitoring or avoidance is needed. Katzung's Basic and Clinical Pharmacology, 16th ed., p. 1780.
Bottom line: CoQ10 is biologically plausible and may modestly improve outcomes in heart failure as an adjunct, but it is not routine first-line cardiac therapy. Recent systematic-review evidence supports a possible benefit, while certainty remains incomplete, especially alongside current standard heart-failure regimens.
This is a shared conversation. Sign in to Orris to start your own chat.